The lacrimal apparatus is the collective system of structures that produce, distribute, and drain tears from the surface of the eye. It includes the lacrimal gland (tucked under the outer edge of the upper eyelid), the thin tear film that coats the eye’s surface, and a series of small channels and ducts that funnel used tears down into the nasal cavity. Most people only think about this system when something goes wrong with it, but it runs continuously, keeping the cornea moist, clear, and defended against infection with every blink.
How Tears Are Made
The lacrimal gland sits in a shallow depression of the skull bone just above and to the outer side of each eye. It is roughly the size and shape of an almond, and its job is to manufacture the watery (aqueous) layer of the tear film. The gland’s secretory cells produce a surprisingly complex fluid containing water, salts, and proteins, with at least five types of neurotransmitter receptors and three separate internal signaling pathways coordinating the process.1PubMed. The Lacrimal Gland and Its Veil of Tears Smaller accessory lacrimal glands scattered in the conjunctiva (the thin membrane lining the inner eyelids) contribute a baseline level of moisture even between blinks.
Tear production is not a simple faucet. It is actively regulated by the nervous system through a reflex arc. Sensory nerves on the cornea and conjunctiva detect dryness, irritation, or foreign particles, then signal the brain. The brain responds by activating parasympathetic and sympathetic nerves that run to the lacrimal gland, triggering the release of neurotransmitters that ramp up water, electrolyte, and protein secretion.2PubMed Central. Neural regulation of lacrimal gland secretory processes: relevance in dry eye diseases Research in mice has clarified that the parasympathetic branch plays the dominant role: when parasympathetic nerves to the lacrimal gland were experimentally cut, tear secretion dropped immediately and the gland eventually shrank and lost its internal structure, while cutting only the sympathetic nerves did not produce the same damage.3PubMed. Identification of Lacrimal Gland Postganglionic Innervation and Its Regulation of Tear Secretion
This neural wiring also explains emotional crying, though that pathway is far more complex. Emotional tears engage higher brain centers alongside the reflex circuitry, folding in facial muscle contractions, vocalizations, and subjective emotional experience. Understanding the neurobiology of emotional crying remains a challenge precisely because so many systems fire at once.
The Blink-Driven Pump
Once tears are produced and spread across the eye, they need somewhere to go. The drainage side of the lacrimal apparatus starts at two tiny openings called puncta, one on the inner edge of each eyelid. Tears flow from the puncta into short channels (canaliculi) that merge and empty into a small pouch called the lacrimal sac, which sits in a bony groove along the side of the nose. From there, a longer tube called the nasolacrimal duct carries the fluid down into the nasal cavity, which is why your nose runs when you cry.
What powers this drainage is not gravity alone. It is an active pump driven by the muscles you use to blink. The mechanism has been studied for decades, and while researchers have proposed slightly different models, the core idea is consistent. When you close your eyelids, the orbicularis muscle around the eye contracts. This squeezes the canaliculi shut, pushing their contents toward the lacrimal sac. At the same time, the contraction pulls on the lateral wall of the sac, creating a drop in pressure that acts like suction, drawing tears in from the canaliculi.4PubMed. Tricompartment model of the lacrimal pump mechanism When the lids open again, the muscle relaxes, the sac springs back, and a vacuum is created that reloads the system with fresh tear fluid for the next cycle.5PubMed. Ultrasonic visualization of the effect of blinking on the lacrimal pump mechanism
More recent anatomical work has refined this picture. A deeper muscle layer sometimes called Horner-Duverney’s muscle, which is part of the orbicularis, wraps around the canaliculi in a way that compresses different segments of the drainage tubes at slightly different moments during a blink. The first two-thirds of the canaliculi get squeezed early, pressing fluid toward the sac, while the section closest to the sac gets compressed from behind, giving the fluid an extra push.6PubMed. New insights into the lacrimal pump The muscle fibers involved are a mix of fast-twitch and fatigue-resistant types, well suited for a movement that happens roughly fifteen to twenty times a minute all day long.
What Tears Actually Contain
Tears are not just salt water. The tear film has three layers working together: an outer oily (lipid) layer that slows evaporation, a middle aqueous layer produced mainly by the lacrimal gland, and an inner mucin layer that helps the whole film stick to the eye’s surface. The aqueous layer carries an arsenal of antimicrobial compounds. Lysozyme and lactoferrin are among the most abundant. Lysozyme attacks bacterial cell walls directly; lactoferrin binds iron, starving bacteria of a nutrient they need to grow.7PubMed Central. Tear Lactoferrin and Lysozyme as Clinically Relevant Biomarkers of Mucosal Immune Competence
Beyond those two, tears contain a broad collection of additional antimicrobial molecules, including members of the cationic antimicrobial peptide family and surfactant protein-D, with newer candidates still being identified.8PubMed Central. Antimicrobial compounds in tears This chemical defense is one reason the eye can remain exposed to the environment without becoming constantly infected. When tear production drops or the composition shifts, the eye loses this protective shield, and the risk of surface infections and inflammation climbs.
Why Screen Time Makes Your Eyes Dry
The lacrimal pump depends on blinking, and blinking is one of the first casualties of prolonged screen use. The commonly accepted explanation is that staring at a digital screen reduces both the frequency and the completeness of blinks. Between each blink, the aqueous layer of the tear film evaporates. A full blink replenishes it by spreading fresh tears from the lacrimal gland and fresh lipids from the meibomian glands (oil-producing glands in the eyelids) back across the surface. When blinks are fewer or only partial, the tear film is not adequately restored, and evaporative loss accelerates. Over time, this can initiate a cycle of chronic ocular surface dryness.9PubMed Central. The Relationship Between Dry Eye Disease and Digital Screen Use
Practical steps that ophthalmologists commonly recommend include the 20-20-20 rule (every 20 minutes, look at something 20 feet away for 20 seconds), consciously blinking more during focused tasks, and using humidifiers in dry indoor environments. These measures do not treat underlying lacrimal gland disease, but for the large number of people whose dryness is mostly an evaporation and blinking problem, they can make a real difference.
Medications That Interfere With Tear Production
A number of common prescription and over-the-counter drugs can reduce tear output or destabilize the tear film. Systemic medications may do this through their intended pharmacological action (antihistamines dry mucous membranes across the body, not just in the nose), and topical eye drops can cause trouble through their active ingredients or, frequently, through the preservatives added to keep the bottle sterile. The effects are probably additive, meaning someone taking two or three drying medications at once is at higher risk than someone on just one.10PubMed Central. The role of medications in causing dry eye Common culprits include antihistamines, decongestants, antidepressants, beta-blockers, diuretics, and isotretinoin. If you are dealing with persistent dry eyes, it is worth reviewing your medication list with a doctor to see whether any of them could be contributing.
Aging and Autoimmune Disease
The lacrimal gland does not age gracefully. In animal models of aging, one of the earliest changes is a decline in the gland’s response to neural stimulation, meaning the signals telling the gland to secrete become less effective even before the gland tissue itself deteriorates. Alongside this, mast cells accumulate within the gland and cellular waste products (lipofuscin) build up, markers of chronic low-grade inflammation and declining cellular housekeeping.11PubMed Central. The aging lacrimal gland: changes in structure and function These changes help explain why dry eye symptoms become more common with age, particularly after middle age, even in people with no other eye disease.
A more severe form of lacrimal gland destruction occurs in Sjögren’s syndrome, a chronic autoimmune disease in which the body’s immune cells infiltrate and gradually destroy exocrine glands, particularly the lacrimal and salivary glands. Sjögren’s is considered the most representative cause of aqueous-deficient dry eye, the type where the problem is genuinely insufficient tear production rather than excessive evaporation. Both the innate and adaptive branches of the immune system participate actively, driving inflammation on the ocular surface that further reduces lacrimal secretion and damages the cornea and conjunctiva.12PubMed Central. Ophthalmologic Manifestations of Primary Sjögren’s Syndrome The condition is chronic and progressive, and treatment focuses on managing symptoms (artificial tears, anti-inflammatory drops, punctal plugs to slow tear drainage) alongside systemic therapy for the autoimmune process itself.
Blocked Drainage and Dacryocystitis
On the drainage side, the most common problem is obstruction of the nasolacrimal duct. When the duct becomes blocked, tears have nowhere to go, and the eye waters constantly, a condition called epiphora. Stagnant fluid in the lacrimal sac can become infected, producing dacryocystitis, a painful red swelling beside the nose that may discharge pus. The most common site of blockage is the distal (lower) portion of the nasolacrimal duct.13PubMed. Dacryocystitis: Systematic Approach to Diagnosis and Therapy
Microbiology studies of these infections show a mix of organisms. In a study of 100 samples from patients with epiphora or dacryocystitis, about 79% were culture-positive. The most frequently isolated group was coagulase-negative staphylococci, followed by anaerobic non-spore-forming rods and Pseudomonas aeruginosa. Gram-negative organisms were isolated more often in chronic dacryocystitis than in simple epiphora. Among the antibiotics tested, ciprofloxacin showed the broadest effectiveness against both gram-positive and gram-negative bacteria in these samples.14PubMed Central. Microbiology of primary acquired nasolacrimal duct obstruction: simple epiphora, acute dacryocystitis, and chronic dacryocystitis
In newborns, a blocked nasolacrimal duct is extremely common because the membrane at the bottom of the duct sometimes has not fully opened at birth. Most cases resolve on their own within the first year. In adults, obstruction tends to be acquired and is less likely to clear without intervention.
Surgery for Nasolacrimal Duct Obstruction
When a blocked nasolacrimal duct does not respond to conservative treatment, the standard surgical fix is a dacryocystorhinostomy, or DCR. The procedure creates a new passage between the lacrimal sac and the nasal cavity, bypassing the blocked duct entirely. It can be performed externally (through a small incision on the side of the nose) or endonasally (from inside the nose, often with a laser or mechanical instruments).
The evidence on which approach works better is fairly clear. A Cochrane systematic review found that laser-assisted endonasal DCR had a lower success rate than external DCR, roughly 63% versus 91%. However, mechanical endonasal DCR (done without a laser) achieved about the same success rate as external DCR, around 90% in both groups.15Cochrane Database of Systematic Reviews. Endonasal versus external dacryocystorhinostomy for nasolacrimal duct obstruction A more recent meta-analysis comparing transcanalicular laser-assisted DCR to external DCR confirmed the general pattern: external DCR had higher anatomical and functional success rates, while the laser approach had shorter operating times and fewer intraoperative complications.16PubMed Central. Transcanalicular laser-assisted and external dacryocystorhinostomy anatomical and functional success in primary acquired nasolacrimal duct obstruction: systematic review and meta-analysis
Another variable is whether a silicone stent (a thin tube) is placed inside the new passage during surgery to keep it open while it heals. A review of multiple studies found that silicone intubation improved success rates, with outcomes ranging from 80% to 95% when a stent was used.17PubMed Central. Success Rate of External Dacryocystorhinostomy With and Without Stent The stent is typically removed a few months after surgery once the tissue has healed around the new opening.
How the Lacrimal Gland Forms Before Birth
The lacrimal gland develops through a process called branching morphogenesis, which is the same general mechanism used by the lungs, kidneys, and salivary glands to build their complex tree-like structures. Starting from a simple bud of tissue, the developing gland branches repeatedly to form the elaborate network of ducts and secretory clusters (acini) seen in the adult. This process is governed by specific genes expressed at the growing tips of the branches. Research in mice has identified the gene ADAMTS18 as one regulator of this branching. Its messenger RNA is concentrated in the epithelial tips of the embryonic lacrimal gland, and when the gene is knocked out, the number of epithelial buds and branches drops significantly during fetal development. Mice lacking ADAMTS18 also go on to develop dry eye, suggesting that abnormal gland architecture from the start can have lasting consequences for tear production.18PubMed. ADAMTS18 regulates early branching morphogenesis of lacrimal gland and has a significant association with the risk of dry eye in mice
An Evolutionary Perspective
The lacrimal drainage system is fundamentally a terrestrial adaptation. Aquatic vertebrates like fish do not need it because their eyes are constantly bathed in water. As vertebrates moved onto land, the eye’s surface became exposed to air and needed a dedicated system to stay moist and protected. The evolutionary development of the lacrimal drainage pathway is closely linked to two other structures: the Harderian gland (found in many reptiles, birds, and amphibians, though vestigial in adult humans) and the vomeronasal organ, a chemical-sensing structure used by many animals to detect pheromones.19PubMed. A major review on disorders of the animal lacrimal drainage systems: Evolutionary perspectives and comparisons with humans In some species, the lacrimal drainage system still carries fluid to the vomeronasal organ, linking tear drainage with chemical sensing. In humans, the vomeronasal organ is largely non-functional, and the drainage pathway simply empties into the nasal cavity.
Regenerative Medicine and Lacrimal Gland Repair
For people whose lacrimal glands are severely damaged by autoimmune disease or other conditions, artificial tears provide only temporary relief. A more ambitious goal is to repair or replace the gland itself. Several lines of research are converging on this problem.
One approach involves identifying progenitor cells within the lacrimal gland that can regenerate functional tissue. In a mouse study, researchers isolated a specific population of epithelial progenitor cells from adult lacrimal glands, characterized by particular surface markers. These cells could form acini and ducts in three-dimensional culture. When transplanted into the lacrimal glands of mice with a form of aqueous-deficient dry eye, the progenitor cells engrafted into the secretory structures, reduced immune cell infiltration, and substantially improved gland function and structural integrity.20PubMed Central. Lacrimal Gland Repair Using Progenitor Cells
Mesenchymal stem cells delivered to the lacrimal gland have also improved tear secretion in dry eye mouse models, and early human studies are underway. The therapeutic mechanism appears to involve immune modulation alongside direct gland repair. Meanwhile, tissue engineering approaches are exploring new scaffolds, organoid generation techniques, and three-dimensional bioprinting to build functional lacrimal gland units from scratch.21Current Ophthalmology Reports. Approaches to Restoring Lacrimal Gland Function: From stem Cells to Tissue Engineering Lacrimal gland organoids, miniature lab-grown versions of the gland, are a particularly active area, with researchers refining techniques using both tissue-derived and stem-cell-derived starting materials.22PubMed. Advances in lacrimal gland organoid development: Techniques and therapeutic applications None of these approaches are ready for routine clinical use yet, but the progress from proof-of-concept in mice to early human trials has been faster than many in the field expected.